NSAM
EW icon

North Star Asset Management’s Edwards Lifesciences EW Stock Holding History

North Star Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.47M Sell
71,575
-650
-0.9% -$54.5K 0.25% 94
2026
Q1 		$5.78M Buy
72,225
+3,504
+5% +$289K 0.25% 95
2025
Q4 		$5.86M Buy
68,721
+8,940
+15% +$734K 0.24% 93
2025
Q3 		$4.65M Buy
59,781
+3,844
+7% +$300K 0.19% 100
2025
Q2 		$4.37M Buy
55,937
+8,373
+18% +$624K 0.19% 99
2025
Q1 		$3.45M Buy
47,564
+12,293
+35% +$880K 0.16% 105
2024
Q4 		$2.61M Buy
35,271
+17,508
+99% +$1.23M 0.12% 118
2024
Q3 		$1.17M Buy
+17,763
New +$1.29M 0.05% 167

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

North Star Asset Management's EW Position: Q2 2026 in Review

North Star Asset Management reduced its Edwards Lifesciences (EW) stake by 0.9% in Q2 2026, selling an estimated $54.5K and leaving 71,575 shares worth $6.47M. The position accounts for 0.25% of the portfolio, ranked #94.

North Star Asset Management first reported a position in EW in Q3 2024 and has held it in 8 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • North Star Asset Management held 71,575 shares of Edwards Lifesciences worth $6.47M as of Q2 2026.
  • North Star Asset Management sold 650 Edwards Lifesciences shares in Q2 2026, an estimated $54.5K.
  • Edwards Lifesciences made up 0.25% of North Star Asset Management's portfolio in Q2 2026, its #94 holding.
  • North Star Asset Management first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 8 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on North Star Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.